Intermedical UK exhibits the new and improved NObreath at ARTP 2019

Bedfont’s long-standing UK distributor, Intermedical UK, will be exhibiting their breath analysis medical products at the annual ARTP conference.

Intermedical UK, a bistributor for nearly 10 years, will be exhibiting the 2^nd generation NObreath at the annual Association for Respiratory Technology & Physiology (ARTP) conference and can be found at Stand 25.

The NObreath^® offers a quick, simple and non-invasive method of measuring FeNO to assess airway inflammation.It aids in the diagnosis and management of asthma.

Interpreting FeNO levels aids in identifying patients who do/do not require on-going treatment¹ whilst also differentiating between allergic (eosinophilic) and non-allergic asthma², and if used daily, FeNO measurements can help to predict exacerbations and attacks³.

New Features

The 2^nd generation NObreath^® has a fresh and aesthetically pleasing design with a full-colour touchscreen. New features of the also include the ability to save patient profiles on the device, Bluetooth connectivity, and SteriTouch^® technology for optimum infection control. Furthermore, the NObreath® comes with free patient management software allowing the equipment to synchronise with a PC. This enables reports to be generated, data to be backed up, and much more.

The Acting Managing Director at Intermedical, Livio Gagliardi, said – “We’re excited to bring the NObreath^® to ARTP this year. It’s a great opportunity to talk about the benefits of measuring FeNO when monitoring asthma and airway inflammation – especially now it is recommended in the NICE guidance. We believe that the new NObreath^® will make FeNO monitoring quicker and easier for healthcare professionals and patients alike.”

This year, ARTP is taking place between 31 January and 1^st February in Glasgow.

REFERENCES

1. Andrew D. Smith, Jan O. Cowan, Sue Filsell, Chris MacLachlan, Gabrielle Monti-Sheehan, Pamela Jackson and D. Robin Taylor. Diagnosing Asthma: Comparisons between Exhaled Nitric Oxide Measurements and Conventional Tests. Am J Respir Crit Care Med Vol 169. pp 473-478, 2004.
2. Coumou HBel E. Improving the diagnosis of eosinophilic asthma [Internet]. Taylor and Francis online. 2017 [cited 15 March 2017]. Available from: http://www.tandfonline.com/doi/full/10.1080/17476348.2017.1236688
3. Harkins M. Exhaled Nitric Oxide Predicts Asthma Exacerbation [Internet]. Taylor & Francis. 2017 [cited 21 September 2017]. Available from: http://www.tandfonline.com/doi/abs/10.1081/JAS-120033990